ReviewCancers2025

Efficacy and Safety of TROP-2-Targeting Antibody-Drug Conjugate Treatment in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer: A Systematic Review and Pooled Analysis of Reconstructed Patient Data.

Sara Stumpo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.